ASCEND BY NTHRYS
Research Abroad Products

Molecular Pharmacology Project Topics

Browse all focused areas across all project categories under this field.

Showing 145–156 of 200 project topics
Off-Target Kinase Liability Assessment Service
Expert consulting service combining biochemical profiling, cellular assays, and predictive modeling to quantify off-target risk for lead compounds across multiple kinase families. Justifies regulatory strategy decisions and improves clinical trial safety profiles, commanding premium service fees.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Recombinant Kinase Domain Protein Library
Standardized, validated recombinant kinase constructs available as commercial reagents for in-house screening programs with guaranteed lot-to-lot consistency and pre-characterized activity. Eliminates production bottlenecks and enables 24-month product contracts with pharmaceutical and biotech clients.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Kinase Selectivity Patent Landscape Intelligence Tool
Subscription-based software that monitors competitive kinase selectivity claims, synthesis routes, and assay methods across 50+ patent databases with automated alerts. Protects R&D investment by identifying freedom-to-operate gaps and informing licensing negotiation strategy.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Cellular Kinase Activity Biomarker Testing Platform
Comprehensive cell-based assay platform measuring kinase substrate phosphorylation in native cellular contexts with multiplexing capability across 12+ kinases simultaneously. Improves pharmacodynamic readouts for clinical studies and supports precision medicine stratification strategies.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Kinase Selectivity Training and Certification Program
Online and on-site educational modules covering kinase biology, assay design, data interpretation, and regulatory expectations with industry-recognized certification. Creates sustained revenue through licensing to CROs and biotech companies while building brand authority in the space.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
Integrated Kinase Selectivity Decision Support Software
Enterprise software integrating structural docking, in vitro selectivity data, cellular potency, and ADMET properties into unified selectivity scoring and optimization algorithms. Reduces time-to-candidate by 35% and improves development success rates, supporting enterprise licensing models.
Kinase Molecular Pharmacology Selectivity Tools Click to view more details →
AI-Powered Blood-Brain Barrier Permeability Prediction Platform
A machine learning SaaS platform that predicts blood-brain barrier penetration for drug candidates using proprietary neural networks trained on extensive BBB transport data. This accelerates lead optimization cycles, reduces failed clinical candidates, and enables pharma companies to charge premium licensing fees for predictive analytics.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →
High-Throughput Neurotoxicity Screening Service for CNS Therapeutics
A commercial testing service utilizing automated patch-clamp and calcium imaging platforms to rapidly assess off-target neurotoxicity across ion channels and receptors. Biotech and pharma firms pay per-sample fees, generating recurring revenue while de-risking their CNS pipelines before expensive IND applications.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →
Computational Target Selectivity Engine for CNS Drug Candidates
A cloud-based molecular modeling tool that maps ligand binding specificity across CNS receptor subfamilies and off-target sites using advanced docking and free energy calculations. Monetized through subscription tiers and per-project analysis fees, helping companies optimize selectivity profiles and reduce attrition rates.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →
Microglial Activation Biomarker Discovery and Validation Platform
A specialized platform combining high-content imaging, single-cell RNA-seq analysis, and proprietary algorithms to identify and validate microglial activation markers for neuroinflammatory indications. Pharma partners license the biomarker assays, enrichment algorithms, and patient stratification tools for their clinical programs.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →
Tau and Amyloid-Beta Targeting Scaffold Design Tool
An integrated structure-activity relationship (SAR) software platform combining 3D protein modeling, fragment-based design, and synthetic accessibility predictions for tau and amyloid aggregates. It enables neurodegenerative drug developers to accelerate lead series optimization and commercializes through licensing fees and milestone-based partnerships.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →
Pharmacokinetic-Pharmacodynamic Bridging Service for CNS Drugs
A contract research offering that couples in vitro target engagement assays, ex vivo receptor occupancy studies, and PK profiling to generate translational PK-PD models for CNS assets. CRO generates revenue through service contracts and enables biotech clients to predict efficacious doses earlier in development.
CNS Molecular Pharmacology Drug Design Platforms Click to view more details →